Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000525701 | SCV000652291 | benign | Usher syndrome type 3B | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001573133 | SCV000723961 | benign | not provided | 2018-06-07 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22930593) |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000525701 | SCV000745441 | benign | Usher syndrome type 3B | 2015-01-15 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001573133 | SCV001473370 | benign | not provided | 2023-09-11 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001573133 | SCV002010491 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001573133 | SCV002586082 | benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | HARS1: BS1, BS2 |
Ambry Genetics | RCV000606943 | SCV002755065 | likely benign | not specified | 2021-02-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory of Diagnostic Genome Analysis, |
RCV001573133 | SCV001798529 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000606943 | SCV001919773 | benign | not specified | no assertion criteria provided | clinical testing |